CDX2 and adenocarcinoma: In addition, the high percentage of negativity for CDX2 of small/large bowel MCs and undifferentiated/rhabdoid carcinomas may aid in their differential diagnosis with poorly differentiated conventional adenocarcinomas, most of which are CDX2‐positive.15, 44